Frost & Sullivan Independent Equity Research

Brainsway Ltd: The Company continues to generate consistent growth based on the rental model with sufficient cash available for 2018; Mild setback in FDA marketing approval (OCD); Price target remains within the forecast range.


Company: Brainsway Ltd.        

Sector: Medical Devices

Report type: Q-4 and Annual (2017) Updates

For all past reports click here

Published on: 10 April, 2018